Evidence map›Paper›PMID 39158281›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Gpx4 Regulates Invariant NKT Cell Homeostasis and Function by Preventing Lipid Peroxidation and Ferroptosis.

Sophia P M Sok, Kaitlyn Pipkin, Narcis I Popescu, Megan Reidy, Bin Li, Holly Van Remmen, Mike Kinter, Xiao-Hong Sun, Zhichao Fan, Meng Zhao

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Metabolic control of innate-like T cells.Nature reviews. Immunology · 2026
    Review
  8. Review
  9. [Research progress on the role of invariant natural killer T cells in immune-mediated liver injury].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sophia P M SokArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0001-5084-068X
Kaitlyn PipkinArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Narcis I PopescuArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0002-4809-9885
Megan ReidyArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0009-0009-6841-5353
Bin LiDepartment of Cellular and Molecular Medicine, School of Medicine, University of California-San Diego, La Jolla, CA.ORCID 0000-0003-2734-6418
Holly Van RemmenAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0003-0883-0642
Mike KinterAging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.
Xiao-Hong SunArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0003-0572-2662
Zhichao FanDepartment of Immunology, School of Medicine, UConn Health, Farmington, CT.
Meng ZhaoArthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK.ORCID 0000-0001-6392-4954

Funding

Proteomics CoreP20GM103447 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Mark L Lang · 2012 to 2026
$60.2M
Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI COGGESHALL, KENNETH MARK · 2004 to 2023
$56.2M
Viral sensor IFIH1 promotes SLE through an altered interferon programP20GM139763 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Kenneth M Humphries · 2021 to 2026
$20.3M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
cGMP Manufacture, Fill-Finish, Release, Analytical and Stability Testing and Stability Program of a Nanoparticle Based HIV Envelope Vaccine75N93022D00005 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI HASSELL, THOMAS · 2022 to 2025
$8.0M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
The role of mitochondrial regulation in cell lineage specification and functionR35GM147713 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Meng Zhao · 2022 to 2026
$2.3M
Molecular mechanism and preclinical translation of beta2 integrin auto-inhibition on neutrophil arrest and inflammationR01HL145454 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI FAN, ZHICHAO · 2019 to 2023
$2.1M
5-Laser Cytek Aurora Spectral Flow CytometerS10OD028479 · OD · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2020 to 2020
$317k
HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL-145454HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM-103447HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM-137786HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM-139763HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM-147713HHS | NIH | National Institute of General Medical Sciences (NIGMS) GM-147713-02S1HHS | NIH | NIH Office of the Director (OD) S10OD028479NHLBI NIH HHS 75N92020D00005NHLBI NIH HHS R01 HL145454NIAID NIH HHS 75N93022D00005NIAID NIH HHS 75N93023D00005NIAID NIH HHS U19 AI062629NIDA NIH HHS 75N95020D00005NIGMS NIH HHS P20 GM103447NIGMS NIH HHS P20 GM139763NIGMS NIH HHS R24 GM137786NIGMS NIH HHS R35 GM147713NIH HHS S10 OD028479ORFDO NIH HHS 75N99020D00005Presbyterian Health Foundation (PHF) Collaborative Research Grant
6 · The paper itself

Abstract

Invariant NKT (iNKT) cells are a group of innate-like T cells that plays important roles in immune homeostasis and activation. We found that iNKT cells, compared with CD4+ T cells, have significantly higher levels of lipid peroxidation in both mice and humans. Proteomic analysis also demonstrated that iNKT cells express higher levels of phospholipid hydroperoxidase glutathione peroxidase 4 (Gpx4), a major antioxidant enzyme that reduces lipid peroxidation and prevents ferroptosis. T cell-specific deletion of Gpx4 reduces iNKT cell population, most prominently the IFN-γ-producing NKT1 subset. RNA-sequencing analysis revealed that IFN-γ signaling, cell cycle regulation, and mitochondrial function are perturbed by Gpx4 deletion in iNKT cells. Consistently, we detected impaired cytokine production, elevated cell proliferation and cell death, and accumulation of lipid peroxides and mitochondrial reactive oxygen species in Gpx4 knockout iNKT cells. Ferroptosis inhibitors, iron chelators, vitamin E, and vitamin K2 can prevent ferroptosis induced by Gpx4 deficiency in iNKT cells and ameliorate the impaired function of iNKT cells due to Gpx4 inhibition. Last, vitamin E rescues iNKT cell population in Gpx4 knockout mice. Altogether, our findings reveal the critical role of Gpx4 in regulating iNKT cell homeostasis and function, through controlling lipid peroxidation and ferroptosis.

Indexed as

FerroptosisHomeostasisLipid PeroxidationMice, KnockoutNatural Killer T-CellsPhospholipid Hydroperoxide Glutathione PeroxidaseAnimalsFemaleHumansInterferon-gammaMaleMiceMice, Inbred C57BLMitochondriaReactive Oxygen Speciesglutathione peroxidase 4, mouseGPX4 protein, humanInterferon-gammaPhospholipid Hydroperoxide Glutathione PeroxidaseReactive Oxygen Species

Identifiers

PMID39158281
PMCPMC11408103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.